Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients

JUNJI WADA, AKIO YAMASAKI, SHUNTARO NAGAI, KOUSUKE YANAI, KOUTA FUCHINO, CHIZU KAMEDA, HARUO TANAKA, KENICHIRO KOGA, HIROSHI NAKASHIMA, MASAFUMI NAKAMURA, MASAO TANAKA, MITSUO KATANO and TAKASHI MORISAKI
Anticancer Research July 2008, 28 (4C) 2401-2408;
JUNJI WADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AKIO YAMASAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHUNTARO NAGAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOUSUKE YANAI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOUTA FUCHINO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHIZU KAMEDA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HARUO TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENICHIRO KOGA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROSHI NAKASHIMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAFUMI NAKAMURA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAO TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MITSUO KATANO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mkatano@tumor.med.kyushu-u.ac.jp
TAKASHI MORISAKI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 28 no. 4C 2401-2408
PubMed 
18751426

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 2, 2008
  • Revision received May 2, 2008
  • Accepted May 9, 2008
  • Published online July 1, 2008.

Copyright & Usage 
Copyright© 2008 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. JUNJI WADA1,
  2. AKIO YAMASAKI1,
  3. SHUNTARO NAGAI1,
  4. KOUSUKE YANAI1,
  5. KOUTA FUCHINO2,
  6. CHIZU KAMEDA1,
  7. HARUO TANAKA1,
  8. KENICHIRO KOGA1,
  9. HIROSHI NAKASHIMA1,
  10. MASAFUMI NAKAMURA1,
  11. MASAO TANAKA3,
  12. MITSUO KATANO1 and
  13. TAKASHI MORISAKI2
  1. 1Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, Fukuoka
  2. 2Yakuin CA Clinic, Fukuoka, Japan
  3. 3Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka
  1. Correspondence to: Mitsuo Katano, Department of Cancer Therapy and Research, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. Tel: +81 92 6426941, Fax: +81 92 6426221, e-mail: mkatano{at}tumor.med.kyushu-u.ac.jp

Statistics from Altmetric.com

Cited By...

  • 25 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research: 28 (4C)
Anticancer Research
Vol. 28, Issue 4C
July-August 2008
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 10 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients
JUNJI WADA, AKIO YAMASAKI, SHUNTARO NAGAI, KOUSUKE YANAI, KOUTA FUCHINO, CHIZU KAMEDA, HARUO TANAKA, KENICHIRO KOGA, HIROSHI NAKASHIMA, MASAFUMI NAKAMURA, MASAO TANAKA, MITSUO KATANO, TAKASHI MORISAKI
Anticancer Research Jul 2008, 28 (4C) 2401-2408;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Regulatory T-Cells Are Possible Effect Prediction Markers of Immunotherapy for Cancer Patients
JUNJI WADA, AKIO YAMASAKI, SHUNTARO NAGAI, KOUSUKE YANAI, KOUTA FUCHINO, CHIZU KAMEDA, HARUO TANAKA, KENICHIRO KOGA, HIROSHI NAKASHIMA, MASAFUMI NAKAMURA, MASAO TANAKA, MITSUO KATANO, TAKASHI MORISAKI
Anticancer Research Jul 2008, 28 (4C) 2401-2408;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Regulatory T Cells in Angiogenesis
  • The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
  • Immunotherapy Approaches Targeting Regulatory T-Cells
  • Prediction of Response in Cancer Immunotherapy
  • Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
  • Time to Shift the Focus of the War: It Is Not All About the Enemy
  • Google Scholar

More in this TOC Section

  • Impact of Surgery Refusal on Overall Survival in Merkel Cell Carcinoma
  • Association of County-level Social Determinants and Pancreatic Cancer Incidence in the United States
  • Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece
Show more Clinical Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire